LINC02690

Across TCGA pan-cancer cohorts, LINC02690 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02690’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC02690 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02690 is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

LUSC, KICH, and LUAD are the cancer types where LINC02690 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02690 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	II,III,IV	+0.150	<.001	5	view →
KICH	All	All	−0.088	.001	5	view →
LUAD	All	All	+0.087	<.001	5	view →
BRCA	Female	All	+0.038	.004	4	view →
COAD	Female	IV	−0.195	.005	2	view →
KIRC	Male	II,III,IV	−0.058	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02690–LUSC

Open the LUSC breakdown →